ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 628811 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 628811; 2) Community: the network communities that were significantly associated with the response to NSC 628811; 3) Molecule: the relationships between components within communities and NSC 628811; 4) MDR: the compounds that were significantly associated with the NSC 628811.

NSC Compound Enrichment Correlation
NSC 87500 Solacongestidine 0.0459335986102865 0.22289972
NSC 635979 Null 0.0462077035966084 0.31688622
NSC 645892 Naphtho[2,3-f]quinoxaline-7,12-dione, 3-hydroxy-2-methyl- 0.0462077035966084 0.085773079
NSC 662116 4H-Cyclopenta[c]thiophen-4-one, 6-amino-1,3-dibromo- 5,6-dihydro-, hydrochloride 0.0462077035966084 0.35217945
NSC 673188 - 0.0462077035966084 0.38101062
NSC 676343 Null 0.0462077035966084 0.20163069
NSC 676916 1-[m-methyl anilino malonyl]-3-methyl-4-[4'-.beta.-sulphato ethyl sulphonyl phenyl azo]-5-pyrazolone 0.0462077035966084 0.40766453
NSC 677959 16.beta.-N-methylpiperazino-5-androstene-3.beta.,17.beta.-diol 0.0462077035966084 0.22824026
NSC 682827 Propanimidoyl chloride, 2-methyl- N-[[[[3-(trifluoromethyl)phenyl]amino]carbonyl]oxy]- 0.0462077035966084 0.28781505
NSC 682831 Butanimidoyl chloride, N-[[[(3-fluorophenyl)amino] carbonyl]oxy]- 0.0462077035966084 0.31605207
Total:135  Current:125    [First] [Prev] [Next] [Last]